Company: VCIG
Filing Date: 2025-09-25
Form Type: F-3
Source: 0001213900-25-091277
Chunk: 56

Company: VCI Global Ltd
Filing Date: 2025-09-25
Form: F-3
Chunk 56
---
 judgment must be based on a cause of action recognized under the law of the BVI;
(b) the foreign judicial proceeding must have identical parties and identical issues; (c) the foreign judgment must be rendered
by a court with judicial authority; (d) the judgment must be final and conclusive; and (e) the judgment debtor must either
have been present in the foreign country at the time the foreign proceedings were commenced, or have submitted to the jurisdiction of
the foreign court by voluntarily appearing in the foreign proceedings, or prior to the commencement of those proceedings, agreed to submit
to the jurisdiction of the foreign court in respect of the subject matter of the proceedings.

We have appointed Sichenzia Ross Ference Carmel
LLP, 1185 6th Ave 31st Fl, New York, NY 10036 as our agent to receive service of process with respect to any action brought against us
in the United States under the federal securities laws of the United States.

<div align='center'>30

PLAN OF DISTRIBUTION</div>

We may sell the securities from time to time pursuant
to underwritten public offerings, direct sales to the public, negotiated transactions, block trades or a combination of these methods.
We may sell the securities to or through underwriters or dealers, through agents, or directly to one or more purchasers. We may distribute
securities from time to time in one or more transactions:

| ● | at a fixed price or prices, 
 which may be changed;       |

| ● | at market prices prevailing 
 at the time of sale;        |

| ● | at prices related to such prevailing 
 market prices; or                    |

| ● | at negotiated prices. |

A prospectus supplement or supplements (and any
related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the securities,
including, to the extent applicable:

| ● | the name or names of the underwriters, 
 if any;                                |

| ● | the purchase price of the securities                                                      
 or other consideration therefor, and the proceeds, if any, we will receive from the sale; |

| ● | any options under which underwriters        
 may purchase additional securities from us; |

| ● | any agency fees or underwriting                                               
 discounts and other items constituting agents’ or underwriters’ compensation; |

| ● | any public offering price; |

| ● | any discounts or concessions                 
 allowed or reallowed or paid to dealers; and